ArticleRSC medicinal chemistry2023

First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators.

Somaya A Abdel-Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.